Low thrombosis rate seen in blood donors and their relatives with inherited deficiencies of antithrombin and protein C: Correlation with type of defect, family history, and absence of the factor V(Leiden) mutation

Blood Coagulation and Fibrinolysis

Volumn 7, Issue 7, 1996, Pages 689-694

  McColl, M ^a,d   Tait, R C ^a   Walker, I D ^b   Perry, D J ^c   McCall, F ^b   Conkie, J A ^b  

^a SOUTHERN GENERAL HOSPITAL   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

^c ROYAL FREE HOSPITAL   (United Kingdom)

^d NHS GREATER GLASGOW AND CLYDE   (United Kingdom)

Author keywords

Antithrombin; APC resistance; Factor V(Leiden) gene mutation; Protein C; Thrombophilia

Indexed keywords

BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 5 LEIDEN;

ADOLESCENT; ADULT; AGED; ANTITHROMBIN III DEFICIENCY; ARTICLE; BLOOD DONOR; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; THROMBOPHILIA; THROMBOSIS;

EID: 0029806166     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-199610000-00005     Document Type: Article

References (25)

1. Tait RC, Walker ID, Perry DJ, et al. Prevalence of antithrombin deficiency in the healthy population. Br J Haematol 1994; 87: 106-112.
2. Tait RC, Walker ID, Reitsma PH, et al. Prevalence of protein C deficiency in the healthy population. Thromb Haemost 1995; 73: 87-93.
3. Lane DA, Olds RJ, Boisclair M, et al. Antithrombin III mutation database: first update. Thromb Haemost 1993; 70: 361-369.
4. Reitsma PH, Bernardi F, Doig RG, et al. Protein C deficiency: a database of mutations, 1995 update. Thromb 'Haemost 1995; 73: 876-889.
5. Dahlback B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognised mechanism characterised by a poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993; 90: 1004-1008.
6. Dahlback B. Inherited thrombophilia: resistance to activated protein C as a pathogenic factor of venous thromboembolism. Blood 1995; 85: 607-614.
7. Hillarp A, Dahlback B, Zoller B. Activated protein C resistance: from phenotype to genotype and clinical practice. Blood Reviews 1995; 9: 201-212.
8. Gandrille S, Grecngard JS, Alhenc-Gelas M, et al. Incidence of activated protein C resistance caused by the ARG 506 GLN mutation in factor V in 113 unrelated symptomatic protein C deficient patients. Blood 1995; 86: 219-224.
9. Zoller B, Berntsdotter A, de Frutos PG, Dahlback B. Resistance to activated protein C as an additional risk factor in hereditary deficiency of protein S. Blood 1995; 85: 3518-3523.
10. Koeleman BPC, van Rumpt D, Hamulyak K, Reitsma PH, Bertina RM. Factor V Leiden: an additional risk factor for thrombosis in protein S deficient families. Thromb Haemost 1995; 74: 580-583.
11. Radtke KP, Lane DA, Greengard JS, Ehrenforth S, Griffin JH. Combined hereditary APC resistance and AT III type II deficiency associated with venous thrombosis. Thromb Haemost 1995; 73: 1377 (abstract).
12. Ireland H, Bayston T, Chowdbury V, et al. Factor V Leiden as an independent risk factor for thrombosis in antithrombin deficiency type II: heparin binding site. Thromb Haemost 1995; 73: 1361 (abstract).
13. Pabinger I, Mustafa S, Rintelen C, Kyrle PA, Lechner K, Mannhalter C. Factor V Leiden mutation (APC resistance) increases the risk for venous thromboembolism in patients with a gene defect of the protein C or protein S gene. Thromb Haemost 1995; 73: 1361a.
14. Boven HHV, Reitsma PH, Rosendaal FR, et al. Interaction of factor V Leiden with inherited antithrombin deficiency. Thromb Haemost 1995; 73: 1256a.
15. Van Boven HH, Reitsma PH, Rosendaal FR, et al. Factor V Leiden (FV R506Q) in families with inherited antithrombin deficiency. Thromb Haemost 1996; 75: 417-421.
16. Pabinger I, Bruckcr S, Kyrle PA, et al. Hereditary deficiency of antithrombin III protein C and protein S: prevalence in patients with a history of venous thrombosis and criteria for rational patient screening. Blood Coag Fibrinol 1992; 3: 547-553.
17. Allaart CF, Poort SR, Rosendaal FR, Reitsma PH, Bcrtina RM, Briet E. Increased risk of venous thrombosis in carriers of hereditary protein C deficiency defect. Lancet 1993; 341: 134-138.
18. Schwarz HP, Fischer M, Hopmeier P, Batard MA, Griffin JH. Plasma protein S deficiency in familial thrombotic disease. Blood 1984; 64: 1297-1300.
19. Pabinger I, Kyrle PA, Heistinger M, Eichinger S, Wittmann E, Lechner K. The risk of thromboembolism in asymptomatic patients with protein C and protein S deficiency: a prospective cohort study. Thromb Haemost 1994; 71: 441-445.
20. De Stefano V, Leone G, Mastrangelo S, et al. Clinical manifestations and management of inherited thrombophilia: retrospective analysis and follow-up after diagnosis of 238 patients with congenital deficiency of antithrombm III protein C protein S. Thromb Haemost 1994; 72: 352-358.
21. Miletich J, Sherman L, Broze G. Absence of thrombosis in subjects with heterozygous protein C deficiency. N Engl J Med 1987; 317: 991-996.
22. Tait RC, Walker ID, Islam SIAM, et al. Protein S deficiency in healthy blood donors. Br J Haematol 1994 (suppl 1); 86.
23. Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995; 346: 1133-1134.
24. Bovill EG, Bauer KA, Dickerman JD, Callas P, West B. The clinical spectrum of heterozygous protein C deficiency in a large New England kindred. Blood 1989; 73: 712-717.
25. Finazzi G, Caccia R, Barbui T. Different prevalence of thromboembolism in the subtypes of congenital antithrombin III deficiency: review of 404 cases. Thromb Haemost 1987; 58: 1094.